EBRD: Shady Dealings Hobble Development Armenia’s Economic Development

YEREVAN, March 11. /ARKA/. Shady dealings hobble development of Armenia’s economy, Valeriu Razlog, head of the EBRD Yerevan Office, said Friday during a round-table discussion.

He said that the EBRD and World Bank’s joint studies proved this. Some 350 entrepreneurs were surveyed in 2009 and 2010.

Razlog said that respondents had pointed out shadow economy, political instability, tax-related and legislative problems and complicated customs management as major obstacles for improvement of business environment.

He stressed that high logistic fees and adverse geographic location hobble export – industrial capacity can satisfy only domestic demand leaving no room for export.

Armenia downgraded its position by four notches in the World Bank’s Doing Business 2010 ranking. The country came 48th among 183 countries slipping from 44th rank in 2009.

The government has said Armenia will reach considerable progress in improvement of its business environment by April 2011. –0–

spot_img

POPULAR

The investment portfolio of Armenian banks in the second quarter amounted to 1.93 trillion drams, a decline of 9.5% year-to-date

The total investment portfolio of commercial banks in Armenia at the end of June 2026 amounted to 1,933,341,220 thousand drams, a decrease of 202.38 billion drams, or 9.48%, year-to-date.

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

Armenian dram weakened against the dollar and strengthened against the euro and ruble: Central Bank

The average market exchange rate for the US dollar to the Armenian dram, formed on the Armenian foreign exchange market as of August 24, 2026, increased by 0.22 points to 365.38 drams compared to August 21.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

LATEST NEWS

spot_imgspot_imgspot_img